Deadpool Stack
Wolverine Stack 10mg (BPC-157 + TB-500), KPV 10mg, Cartalax 20mg — regeneration, inflammation and connective-tissue research stack
For research purposes only. Not for human consumption.
Mechanism of Action
A regeneration-focused research stack pairing the Wolverine Stack (BPC-157 + TB-500) with KPV's anti-inflammatory alpha-MSH signaling and Cartalax's cartilage-tissue bioregulation — targeting tissue repair, inflammation resolution, and connective-tissue integrity in a single protocol.
How It Works
- 1
Wolverine Stack 10mg (BPC-157 + TB-500) drives angiogenesis, fibroblast migration, and actin-mediated tissue remodeling for soft-tissue repair models
- 2
KPV 10mg, the C-terminal alpha-MSH tripeptide, suppresses NF-kB and pro-inflammatory cytokine signaling without melanocortin receptor activation
- 3
Cartalax 20mg (Ala-Glu-Asp-Gly) acts as a Khavinson short peptide bioregulator, modulating gene expression in chondrocytes and connective tissue
- 4
Combined, the three compounds target the repair, inflammation, and structural-matrix arms of recovery research simultaneously
Key Research Benefits
- Multi-pathway tissue repair research
- Inflammation resolution studies
- Cartilage & connective tissue models
- Bundle savings vs. individual vials
Designed for researchers running regeneration and musculoskeletal recovery protocols. Each component is supplied as a separate vial at 99% purity — Wolverine Stack 10mg, KPV 10mg, and Cartalax 20mg — for independent reconstitution and dosing. Research use only.